&nbsp;

Errata-Tables-FR

New

Nov 2025

Document

Errata-Figures

New

Nov 2025

Document

Errata2

New

Nov 2025

Document

Errata-Figures-FR

New

Nov 2025

Drug

nivolumab

Other Name(s): Opdivo®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Updated

Dec 2025

Regimen

EMA-CO

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

Updated

Dec 2025

Regimen

ETOPPAC-CISPPACL

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

Updated

Dec 2025

Regimen

EP-EMA

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

Updated

Dec 2025

Regimen

NIVL+IPIL

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - MSI-H/dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer

New Drug Funding Program

Nivolumab plus Ipilimumab - MSI-H/dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer

Drugs Used:

nivolumab,

ipilimumab

... Show more tags

Quick Link(s):

Regimen Monograph

Updated

Dec 2025

Regimen

NIVL(MNT)

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - MSI-H/dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer

Drugs Used:

nivolumab

... Show more tags

Quick Link(s):

Regimen Monograph

Updated

Dec 2025

Regimen

EXEMRIBO

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

exemestane

Drugs Used:

exemestane,

ribociclib (Unfunded)

... Show more tags